Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey
Naba Saeed(University of Michigan), Monica A. Tincopa(University of California San Diego), David Sengstock(Beaumont Health), Lisa Glass(University of Michigan), Heba Habbal(Beaumont Health), Asad Mahmood(Wayne State University), Sameer D. Saini(University of Michigan)
Cited by 15
Related Papers
Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
|JAMA Network Open|2020|160
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
|The Lancet. Gastroenterology & hepatology|2023|144
Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis
|Transplantation|2019|125
New and emerging treatments for metabolic dysfunction-associated steatohepatitis
|Cell Metabolism|2024|100